). (E) IF staining results showed protein expression of GABARAPL1, FKBP5, PCDH9, and SLAMF8 in TC and RA samples, visualized with DAPI (blue) and specific antibodies (green) (n = 3). The means ± SD are used to represent the data, while ns (not significant), * P < 0.05, ** P < 0.01, and * P < 0.001 indicate significance levels. " width="100%" height="100%">
Journal: Frontiers in Immunology
Article Title: Unveiling potential diagnostic biomarkers for rheumatoid arthritis through integrated gene expression analysis
doi: 10.3389/fimmu.2026.1645257
Figure Lengend Snippet: Analysis of hub gene expression in synovial tissues from RA patients. (A) Representative MRI scans illustrating synovial thickening. (B) H&E staining of synovial tissue in trauma control (TC) and RA samples (n = 3). (C) Comparative analysis of mRNA expression levels for GABARAPL1, FKBP5, MREG, PCDH9, and SLAMF8 in TC and RA samples (n = 9). (D) Quantitative assessment of protein concentrations for GABARAPL1, FKBP5, PCDH9, and SLAMF8 in TC and RA samples (n = 3, the samples derive from the same experiment and that gels/blots were processed in parallel. original blots/gels are presented in Supplementary Figure 1 ). (E) IF staining results showed protein expression of GABARAPL1, FKBP5, PCDH9, and SLAMF8 in TC and RA samples, visualized with DAPI (blue) and specific antibodies (green) (n = 3). The means ± SD are used to represent the data, while ns (not significant), * P < 0.05, ** P < 0.01, and * P < 0.001 indicate significance levels.
Article Snippet: Subsequently, they were incubated with the primary antibodies against PCDH9 (Abcam, ab233710), GABARAPL1 (Abcam, ab109364), FKBP5 (Proteintech, 14155-1-AP), SLAMF8 (Novus Biologicals, AF1907), and GAPDH (Proteintech, 10494-1-AP) for an overnight period at 4°C.
Techniques: Gene Expression, Staining, Control, Expressing